BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lange NW, Salerno DM, Berger K, Cushing MM, Brown RS Jr. Management of Hepatic Coagulopathy in Bleeding and Nonbleeding Patients: An Evidence-Based Review. J Intensive Care Med 2021;36:524-41. [PMID: 32079443 DOI: 10.1177/0885066620903027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tomić Mahečić T, Baronica R, Mrzljak A, Boban A, Hanžek I, Karmelić D, Babić A, Mihaljević S, Meier J. Individualized Management of Coagulopathy in Patients with End-Stage Liver Disease. Diagnostics (Basel) 2022;12. [PMID: 36553179 DOI: 10.3390/diagnostics12123172] [Reference Citation Analysis]
2 Ding JN, Feng TT, Sun W, Cai XY, Zhang Y, Zhao WF. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study. World J Gastrointest Surg 2022; 14(11): 1260-1271 [DOI: 10.4240/wjgs.v14.i11.1260] [Reference Citation Analysis]
3 González-domínguez E, Córdova D, Abad P, González E, González C, Cordero JJ. Trastornos de la coagulación en cirrosis hepática: artículo de revisión. Hepatología 2022. [DOI: 10.52784/27112330.145] [Reference Citation Analysis]
4 Desai S, Subramanian A. Thrombocytopenia in Chronic Liver Disease: Challenges and Treatment Strategies. Cureus 2021;13:e16342. [PMID: 34277309 DOI: 10.7759/cureus.16342] [Cited by in F6Publishing: 1] [Reference Citation Analysis]